128 related articles for article (PubMed ID: 2480933)
1. Conservative management of primary cervical lymphoma using combination chemotherapy: a case report.
Johnston C; Senekjian EK; Ratain MJ; Talerman A
Gynecol Oncol; 1989 Dec; 35(3):391-4. PubMed ID: 2480933
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy for large-cell lymphoma: optimism and caution.
Coleman M
Ann Intern Med; 1985 Jul; 103(1):140-2. PubMed ID: 2408529
[No Abstract] [Full Text] [Related]
3. Treatment of small-cell carcinoma of the cervix with weekly combination chemotherapy.
Tabbara IA; Grosh WA; Andersen WA; Taylor PT; Hahn SS; Stewart FM
Eur J Cancer; 1990; 26(6):748-9. PubMed ID: 1697475
[TBL] [Abstract][Full Text] [Related]
4. Primary stage I-IIE non-Hodgkin's lymphoma of uterine cervix and upper vagina: evidence for a conservative approach in a study on three patients.
Garavaglia E; Taccagni G; Montoli S; Panacci N; Ponzoni M; Frigerio L; Mangili G
Gynecol Oncol; 2005 Apr; 97(1):214-8. PubMed ID: 15790461
[TBL] [Abstract][Full Text] [Related]
5. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis.
Hainsworth JD; Wolff SN; Stein RS; Greer JP; Cousar JB; Greco FA
Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406
[TBL] [Abstract][Full Text] [Related]
6. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma.
Fisher RI; Gaynor ER; Dahlberg S; Oken MM; Grogan TM; Mize EM; Glick JH; Coltman CA; Miller TP
N Engl J Med; 1993 Apr; 328(14):1002-6. PubMed ID: 7680764
[TBL] [Abstract][Full Text] [Related]
7. Primary malignant lymphoma of the uterine cervix shows favorable response to neoadjuvant chemotherapy.
Kuo HC; Chou CY; Chang CH; Liu MT; Tzeng CC; Huang KE
Gynecol Oncol; 1994 Mar; 52(3):408-10. PubMed ID: 7512523
[TBL] [Abstract][Full Text] [Related]
8. [Non-Hodgkin's lymphomas: recent achievements and therapeutic perspectives].
Bron D; Vandenheule B; Stryckmans P
Rev Med Brux; 1985 Sep; 6(7):491-5. PubMed ID: 2417298
[No Abstract] [Full Text] [Related]
9. Early autologous stem-cell transplantation versus conventional chemotherapy as front-line therapy in high-risk, aggressive non-Hodgkin's lymphoma: an Italian multicenter randomized trial.
Martelli M; Gherlinzoni F; De Renzo A; Zinzani PL; De Vivo A; Cantonetti M; Falini B; Storti S; Meloni G; Rizzo M; Molinari AL; Lauria F; Moretti L; Lauta VM; Mazza P; Guardigni L; Pescarmona E; Pileri SA; Mandelli F; Tura S
J Clin Oncol; 2003 Apr; 21(7):1255-62. PubMed ID: 12663712
[TBL] [Abstract][Full Text] [Related]
10. Randomized study comparing doxorubicin, cyclophosphamide, vincristine, methotrexate with leucovorin rescue, and cytarabine (ACOMLA) with cyclophosphamide, doxorubicin, vincristine, prednisone, and bleomycin (CHOP-B) in the treatment of diffuse histiocytic lymphoma.
Newcomer LN; Cadman EC; Nerenberg MI; Chen M; Bertino JR; Farber LR; Prosnitz LR
Cancer Treat Rep; 1982 Jun; 66(6):1279-84. PubMed ID: 6177407
[TBL] [Abstract][Full Text] [Related]
11. Mediastinal large-B-cell lymphoma with sclerosis: a clinical study of 21 patients.
Todeschini G; Ambrosetti A; Meneghini V; Pizzolo G; Menestrina F; Chilosi M; Benedetti F; Veneri D; Cetto GL; Perona G
J Clin Oncol; 1990 May; 8(5):804-8. PubMed ID: 1692089
[TBL] [Abstract][Full Text] [Related]
12. Hematologic malignancies: non-Hodgkin's lymphomas.
DeVita VT
Hosp Pract (Off Ed); 1986 Sep; 21(9):103-18. PubMed ID: 2427535
[No Abstract] [Full Text] [Related]
13. M-Bacod as first treatment for primary CNS lymphoma.
Boiardi A; Salmaggi A; Silvani A
Neurology; 1996 Jan; 46(1):286-8. PubMed ID: 8559406
[No Abstract] [Full Text] [Related]
14. Primary lymphoma of the cervix. A case report.
Bowen DC; Grant MC
S Afr Med J; 1985 Dec; 68(12):889-90. PubMed ID: 3840922
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant combined chemotherapy followed by external whole pelvic irradiation in two cases of primary extranodal non-Hodgkin's lymphoma of the uterine cervix.
Heredia F; Bravo M; Pierotic M; Majlis A; Carmona L
Gynecol Oncol; 2005 Apr; 97(1):285-7. PubMed ID: 15790479
[TBL] [Abstract][Full Text] [Related]
16. [An apparently primary lymphoma of the testicle].
Belbusti F; Signoretti P; Tondi MR; Sparaventi G
G Chir; 1991; 12(8-9):438-40. PubMed ID: 1721520
[TBL] [Abstract][Full Text] [Related]
17. Intensive weekly combination chemotherapy for patients with intermediate-grade and high-grade non-Hodgkin's lymphoma.
Sweetenham JW; Mead GM; Whitehouse JM
J Clin Oncol; 1991 Dec; 9(12):2202-9. PubMed ID: 1720454
[TBL] [Abstract][Full Text] [Related]
18. Rituximab combined with MACOP-B or VACOP-B and radiation therapy in primary mediastinal large B-cell lymphoma: a retrospective study.
Zinzani PL; Stefoni V; Finolezzi E; Brusamolino E; Cabras MG; Chiappella A; Salvi F; Rossi A; Broccoli A; Martelli M
Clin Lymphoma Myeloma; 2009 Oct; 9(5):381-5. PubMed ID: 19858058
[TBL] [Abstract][Full Text] [Related]
19. Sequential multidrug chemotherapy (CHOP-VA-MB) in patients with high-grade non-Hodgkin's lymphoma--a 20-year follow-up.
Björkholm M; Celsing F; Johansson E;
Ann Hematol; 2006 Oct; 85(10):731-3. PubMed ID: 16838163
[No Abstract] [Full Text] [Related]
20. [Induction of remission in patients with non-Hodgkin lymphomas with high degree of malignancy - preliminary comparison of 2 chemotherapy programs: CHOP-B (cyclophosphamide, adriamycin, vincristine, encorton, bleomycin) and MEV-A (methotrexate, cyclophosphamide, vincristine and adriamycin)].
Walewski JA
Nowotwory; 1983; 33(3):259-65. PubMed ID: 6198637
[No Abstract] [Full Text] [Related]
[Next] [New Search]
